| HS Code | 169393 |
| Product Name | Shuanghuanglian Powder Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions |
| Product Type | Veterinary grade active pharmaceutical ingredient (API) in powder form |
| Active Ingredients | Extracts of Lonicera japonica (honeysuckle), Scutellaria baicalensis (baical skullcap), and Forsythia suspensa (weeping forsythia) |
| Physical Form | Fine dry powder for manufacturing veterinary dosage forms |
| Color And Odor | Brown to yellowish-brown powder with characteristic herbal odor and slightly bitter taste |
| Solubility | Partially soluble in water; forms a suspension or solution depending on formulation processing |
| Pharmaceutical Application | Suitable as an API for tablets, injections, capsules, powders, granules, premix, and oral solutions |
| Pharmacological Property | Exhibits antipyretic, anti-inflammatory, antiviral, and antibacterial activities |
| Therapeutic Indication | Used for prevention and treatment of respiratory tract infections, fever, and inflammatory conditions in veterinary medicine |
| Active Marker Compounds | Contains chlorogenic acid, baicalin, and forsythiaside as quality marker compounds |
| Quality Standard | Complies with veterinary pharmacopoeia standards for API raw materials |
| Storage Requirement | Store in a cool, dry, and well-ventilated place; keep container tightly sealed and protected from light |
| Shelf Life | Typically 24 months when stored under recommended conditions |
| Packaging Type | Available in sealed, moisture-resistant veterinary-grade packaging suitable for industrial formulation |
As an accredited Shuanghuanglian Powder Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Packed in 25 kg sealed drums with double polyethylene liners, moisture-proof and light-resistant for safe veterinary use. |
| Container Loading (20′ FCL) | Shuanghuanglian Powder packed in sealed drums, palletized and secured, loaded into one 20′ FCL for safe transport. |
| Shipping | Shipped in sealed, moisture-protected, tamper-evident packaging to preserve potency. Suitable for veterinary pharmaceutical manufacturing; not for human use. Transport at ambient temperature, away from direct sunlight and humidity. Full documentation, COA, and tracking provided. Export packaging complies with international safety standards for dangerous goods, if applicable. |
| Storage | Store in a cool, dry, well-ventilated area at controlled room temperature, tightly sealed in original containers. Protect from light, moisture, and direct sunlight. Keep away from heat sources, oxidizing agents, and incompatible substances. Ensure container remains closed when not in use. Follow veterinary label guidelines; use within shelf life after opening. |
| Shelf Life | Store in sealed, cool, dry conditions. Shelf life: 24 months from manufacture date when stored properly. |
Injectable-grade processing of Shuanghuanglian Powder Veterinary Grade API on a commercial sterile line requires handling the spray-dried extract as a non-sterile raw material containing residual moisture of ≤5.0% by USP <921> and a bioburden load that must be reduced before the final membrane step. The API consists of the mixed aqueous extract of Lonicera japonica Thunb., Scutellaria baicalensis Georgi, and Forsythia suspensa Vahl., with marker compounds chlorogenic acid, baicalin, and phillyrin quantified by HPLC. The extract is dissolved in water for injection at 40–50 °C under a nitrogen overlay in a jacketed stainless-steel tank equipped with a bottom-entering magnetic impeller operating at 200–300 rpm; prolonged mixing above 60 °C produces browning and precipitates containing polymerized phenolic acids. The solution is adjusted to pH 5.5–6.5 with dilute sodium hydroxide or citric acid, passed through a 0.45 μm polyethersulfone clarifying membrane, and filtered into a sterile hold vessel through a 0.22 μm sterile PES cartridge. Nylon membranes are avoided because the polyphenolic marker compounds chlorogenic acid and baicalin show adsorption losses of 8–15% on polyamide surfaces in production-scale trials; PES shows marker retention above 95% when pre-rinsed with WFI. The filtered solution is filled into type II glass vials under ISO 14644-1 Class 5 conditions. Terminal steam sterilization at 121 °C for 15 min is generally avoided because accelerated studies show chlorogenic acid degradation of more than 10% after one terminal cycle, whereas aseptic filtration with a pre-filtration bioburden limit of ≤10 CFU/100 mL preserves marker recovery above 90% for 24 months at 25 °C/60% RH. Vial headspace is blanketed with nitrogen because residual oxygen initiates dark-coloured oxidation products. The resulting injectable solution is administered to cattle and swine under veterinary supervision for adjunct management of acute febrile respiratory syndrome; batch release includes clarity, pH, sterility by USP <71>, bacterial endotoxins by USP <85>, and HPLC marker retention with system precision not exceeding 1.5% relative standard deviation.
For poultry flocks, Shuanghuanglian Powder Veterinary Grade API is formulated as a water-soluble delivery system by dry blending the extract with dextrose monohydrate, anhydrous citric acid, and sodium citrate in a twin-shell blender. The carrier-to-API ratio is commonly set between 2:1 and 9:1 to achieve a final pourable density of 0.65–0.80 g/cm³. Chlorine residuals above 1.0 mg/L in farm water oxidize the phenolic hydroxyl groups of chlorogenic acid and baicalin, causing a pH-dependent colour shift from pale amber to brown within 2–4 h. Formulators therefore include sodium metabisulfite or ascorbic acid at 0.1–0.3 wt% as an oxygen and chlorine scavenger, while buffering the reconstituted solution to pH 5.8–6.2 to reduce oxidative loss. Hard water containing calcium and magnesium above 150 mg/L as CaCO₃ can complex with flavone glucuronides and reduce the transmission of the reconstituted liquid through a 10 μm screen; tetrasodium EDTA is added at 0.05–0.1 wt% in hard-water regions. The blended powder is filled into low-moisture-transmission foil-laminate sachets because the dried extract absorbs atmospheric moisture above 60% RH and cakes. In drinking water proportioners set to 1:100 stock dilution, the API concentration is adjusted according to the flock bodyweight and the veterinarian’s mg/kg-day prescription; published national field dosages vary, and mixing volumes should be calculated from the approved label rather than from extrapolated in vitro data. Visual observation at production scale shows that high-shear eductor hoppers reduce clumping compared with direct pour-in, because the extract powder has poor dispersibility due to its fine particle fraction below 75 μm.
The incorporation of this extract into complete swine feed does not begin with direct addition of the pure API. A stepwise geometric dilution is performed with a carrier selected on the basis of particle size distribution, oil absorption, and bulk density. Spray-dried Shuanghuanglian Powder Veterinary Grade API typically has a tapped density of 0.35–0.50 g/cm³ and a D90 below 150 μm; blending with calcium carbonate carrier of D50 180–250 μm improves flow and reduces segregation in the finished premix. The sequence starts with a 1:1 API-carrier preblend, then continues at 1:9 and 1:99 dilution stages in a horizontal ribbon mixer with a working capacity of 70% of gross volume. Mixing time is validated not by fixed duration but by sampling from 10 locations using ISO 6497:2005 sampling procedures; the coefficient of variation for the marker compound baicalin should not exceed 5.0% for a batch release. The premix is incorporated at a rate calculated to deliver the prescribed amount of extract per tonne of complete feed. Conditioning ahead of pelleting becomes the critical control point because chlorogenic acid loss accelerates above 65 °C in wet feed; therefore, conditioner temperature is controlled at 60–65 °C with a retention time of 15–20 s, and post-pellet marker retention is maintained above 90% relative to the mash sample. In feed mills where conditioners cannot run below 70 °C, the premix is preferably applied post-pelleting through a liquid or dry microdosing system. Segregation during discharge from bulk feed bins is reduced by matching carrier and feed particle sizes; if the carrier D50 differs from the ground maize D50 by more than 200 μm, stratification of the marker can occur during pneumatic conveying.
| Process Point | Measured Parameter | Acceptance Window | Method/Standard |
|---|---|---|---|
| API preblend | Baicalin content uniformity | ±5% of target | HPLC, CVP 2020 |
| Ribbon mixer final premix | Coefficient of variation across 10 sampling ports | ≤5.0% | ISO 6497:2005 |
| Conditioner | Temperature/retention | 60–65 °C, 15–20 s | In-line RTD |
| Post-pellet premix | Marker retention vs mash | ≥90% | HPLC, CVP 2020 |
Fluid-bed granulation of Shuanghuanglian Powder Veterinary Grade API is used when oral dosing to calves and lambs requires a free-flowing granule with reduced dust and improved palatability. The extract is first blended with lactose monohydrate and microcrystalline cellulose in a high-shear granulator, then an aqueous binder solution of polyvinylpyrrolidone K30 at 3–5 wt% solids is sprayed at 5–10 mL/min per kg of dry charge. The wet mass is dried in a fluid-bed dryer with inlet air temperature of 60±5 °C, while the product bed temperature is kept below 45 °C to protect chlorogenic acid. Dried granules are sieved through 16 mesh and 60 mesh screens; oversized material is dry-milled and re-sieved, while fines are recycled into the next granulation batch at ≤15% of the fresh charge to avoid over-wetting. Loss on drying is controlled at ≤3.0% by USP <731>, and the final sachet fill weight is monitored with an in-line checkweigher rejecting deviations greater than ±2% from target. The moisture-barrier sachet is aluminium-foil laminate because the extract is hygroscopic and marker degradation accelerates above 25 °C/60% RH within open storage. A production-scale bottleneck is the tackiness of the spray-dried extract at product temperatures above 50 °C during fluid-bed drying; this creates lumps on the distributor plate and reduces yield by 3–7% if not controlled by staged air velocity reduction during the final 10 min of drying.
Hard gelatin capsules containing Shuanghuanglian Powder Veterinary Grade API are prepared when once-daily oral administration to horses must mask the bitterness of baicalin. The formulation uses lactose monohydrate as the main diluent and sodium starch glycolate at 2–4 wt% to promote disintegration. Because the spray-dried extract has poor flow with a Carr index above 30, direct fill on an automatic capsule machine requires precompaction or granulation; unlubricated powder sticks to dosator pins when the relative humidity exceeds 55% RH. Magnesium stearate at 0.5–1.0 wt% is added as a lubricant, but overblending beyond 5 min coats the extract particles and delays dissolution. The fill blend is filled into size 0 or 1 hard gelatin capsules at a target fill weight of 350–500 mg depending on the labelled dose. In-process controls include fill weight variation not exceeding ±5% and disintegration times below 15 min by USP <701>. Capsules are packaged in polyvinyl chloride/polyvinylidene chloride/aluminium blisters because the dried extract is hygroscopic. At production scale, the principal failure mode is capsule shell embrittlement when the blend moisture content is below 2%; humidity is therefore maintained at 40–50% RH in the encapsulation suite. Content uniformity of the marker compound baicalin is evaluated by USP <905> to ensure that the low-dose extract is maintained within the accepted pharmacopoeial range despite the poor flow characteristics of the raw powder.
Tableting of Shuanghuanglian Powder Veterinary Grade API is feasible only after granulation or with a highly compressible filler because the spray-dried extract exhibits limited plastic deformation and low bulk density. A typical direct-compression formula consists of microcrystalline cellulose PH-102 at 40–60 wt%, lactose monohydrate at 20–30 wt%, crospovidone at 3–5 wt%, colloidal silicon dioxide at 0.5–1.0 wt%, and magnesium stearate at 0.5–1.0 wt%. The blended powder is compressed on a rotary tablet press with a turret speed of 20–40 rpm and a compression force of 8–18 kN. Tablets with hardness below 40 N show edge chipping during coating, while forces above 20 kN cause capping because the elastic recovery of the extract-rich granules exceeds the binder capacity of microcrystalline cellulose. Tablet weight is controlled at ±5% for individual units and content uniformity complies with USP <905> for the marker compound baicalin. The tablets are film-coated with an aqueous hydroxypropyl methylcellulose system at a weight gain of 2–3% to reduce bitterness and improve stability. A production-scale constraint is the low melting point of residual extract sugars; when press dwell time is prolonged by tooling wear, material adheres to the punch tips and requires polishing every 4 h of continuous operation.
Multi-dose oral solutions for swine and poultry are prepared by first dispersing Shuanghuanglian Powder Veterinary Grade API in a co-solvent mixture of propylene glycol and purified water, then pH adjustment to 6.0–6.8 with citrate buffer. High-shear mixing at 3000–5000 rpm for 10–15 min disperses the fine extract particles, but full dissolution of all polysaccharide components is rarely achieved; a clarifying filtration through 5 μm polypropylene depth media removes visible particulates without stripping the active markers. Sodium benzoate at 0.1–0.2% and potassium sorbate at 0.1–0.2% are used as preservatives in multi-dose presentations, and preservative efficacy is evaluated according to USP <51>. The solution is filled into amber polyamide-coated polyethylene terephthalate bottles with child-resistant closures. Oxidative darkening is retarded by adding sodium metabisulfite at 0.05–0.1% and by purging the headspace with nitrogen. A common production deviation is the appearance of a haze after 7 days at 40 °C when the ratio of buffer to extract solids is below 0.5 mEq/g; the haze is attributed to flocculation of suspended flavonoids in low-ionic-strength media. The finished solution is administered by oral drench or through swine medicator systems; the dose is expressed on the label as mg of extract per kg bodyweight and is adjusted by the veterinarian for the target species.
| Dosage Form | Release Test | Acceptance Criterion | Reference Standard |
|---|---|---|---|
| Injectable solution | Sterility; bacterial endotoxins; marker content | Sterile; ≤0.5 EU/mg; 90–110% | USP <71>; USP <85>; CVP 2020 |
| Soluble powder | Loss on drying; marker content; bioburden | ≤5.0%; 90–110%; ≤10³ CFU/g | USP <731>; CVP 2020; USP <61> |
| Feed premix | Marker uniformity; sieve distribution | CV ≤5.0%; D90 ≤500 μm | ISO 6497:2005; ASTM D1921 |
| Oral granules | Loss on drying; fill weight; dissolution assay | ≤3.0%; ±2%; Q ≥75% in 45 min | USP <731>; USP <905>; USP <711> |
| Hard capsules | Disintegration; content uniformity | ≤15 min; AV ≤15 | USP <701>; USP <905> |
| Tablets | Hardness; friability; content uniformity | 40–90 N; ≤1.0%; AV ≤15 | USP <1217>; USP <1216>; USP <905> |
| Oral solution | pH; preservative efficacy; marker content | 6.0–6.8; compendial; 90–110% | USP <51>; CVP 2020 |
Competitive Shuanghuanglian Powder Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8618963613625 or mail to sales10@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8618963613625
Email: sales10@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Shuanghuanglian Powder Veterinary Grade API is a spray-dried or vacuum-dried multi-herb extract prepared from the flower of Lonicera japonica Thunb., the root of Scutellaria baicalensis Georgi, and the fruit of Forsythia suspensa (Thunb.) Vahl. The material is intended as a botanical active pharmaceutical ingredient for incorporation into tablets, injectable powders, hard capsules, soluble powders, granules, premixes, and oral solutions for food-producing and companion animal species. The manufacturer designation for this grade is SHL-VG-API-98; it is differentiated from feed-grade raw herb blends by a defined multi-marker content, controlled microbial quality, and a documented solvent residue profile. The dry powder is typically brownish-yellow to yellowish-brown, has a characteristic aromatic odour, and is standardized on a weight-for-weight basis to the marker compounds baicalin, chlorogenic acid, and forsythin. Because the three marker compounds originate from different botanical organs and vary with plant provenance, harvest year, and extraction solvent, the API grade is released only after high-performance liquid chromatographic profiling against a qualified reference standard. This grade is not a single-entity synthetic molecule; the reported antiviral, antibacterial, and anti-inflammatory activity relevant to veterinary respiratory and enteric indications is attributed to a mixture of flavonoids, phenolic acids, lignan glycosides, and related polyphenolic constituents.
The pharmacopoeial identity of Shuanghuanglian is not established by a single chromatographic peak. Baicalin, a flavone glucuronide from S. baicalensis, is usually the most abundant marker and is determined by HPLC with UV detection at 280 nm. Chlorogenic acid from L. japonica is determined at 327 nm. Forsythin from F. suspensa is determined at 280 nm or 228 nm depending on the monograph method and detector conditions. A representative supplier specification for veterinary-grade extract sets baicalin not less than 5.0% w/w, chlorogenic acid not less than 1.0% w/w, and forsythin not less than 0.3% w/w. The exact acceptance limits nevertheless vary among national veterinary pharmacopoeias and registered product dossiers. The use of three markers prevents suppliers from adjusting one marker by blending with a single enriched extract; it also detects extraction failures specific to one botanical raw material. The ratio of the three botanical ingredients is usually controlled at 1:1:1 by dry herb weight before extraction, but the dry extract is corrected with a carrier such as maltodextrin or dextrin to a defined marker concentration. In addition to marker content, the API specification includes a botanical identity test using thin-layer chromatography, HPLC fingerprint similarity with a reference extract, and physical tests for extractable matter. The botanical identity and purity approach follows the general principles of USP <561> Articles of Botanical Origin for raw plant materials and extracts, with chromatographic method validation under USP <621>. Heavy metals are controlled under USP <233>.
Particle engineering determines whether a botanical API can run on high-speed tablet presses or capsule filling machines without lamination, sticking, or weight variability. The spray-dried Shuanghuanglian powder is typically supplied with a particle size in which not less than 90% passes through an 80-mesh sieve (177 μm), with a D90 value generally not exceeding 250 μm. The bulk density of spray-dried lots is often between 0.35 g/mL and 0.55 g/mL, and the tap density may reach 0.55 g/mL to 0.75 g/mL after 300 taps. The angle of repose for uncompacted powder is commonly above 35°, which indicates marginal flow and explains why direct compression formulations require a glidant, such as colloidal silicon dioxide at 1.0% to 2.0% w/w, or a dry granulation step. The powder is hygroscopic because of the carbohydrate carrier and polyphenolic constituents. Loss on drying at 105°C is usually specified as not more than 6.0% for release, but processing above 60% relative humidity can increase moisture uptake and reduce flow. Tablet formulations containing this API at 20% to 40% w/w are frequently processed by wet granulation with an ethanol-water solution rather than direct compression to avoid stickiness; compression force on a rotary press using 9 mm round concave tooling is typically 12 kN to 22 kN, but published data for this specific extract are limited. Tablets and capsules are coated or stored in aluminium-aluminium blister packaging because the extract is light-sensitive and may darken over time.
| Parameter | Acceptance criterion | Reference/procedure |
|---|---|---|
| Appearance | Brownish-yellow to yellowish-brown powder | Visual inspection |
| Identification | Matches reference TLC fingerprint | Thin-layer chromatography |
| Baicalin | NLT 5.0% w/w | HPLC-UV, 280 nm, USP <621> |
| Chlorogenic acid | NLT 1.0% w/w | HPLC-UV, 327 nm |
| Forsythin | NLT 0.3% w/w | HPLC-UV, 280 nm |
| Loss on drying | NMT 6.0% | 105°C oven method |
| Total ash | NMT 9.0% | 600°C ignition |
| Lead | NMT 5 mg/kg | ICP-MS, USP <233> |
| Cadmium | NMT 0.5 mg/kg | ICP-MS, USP <233> |
| Arsenic | NMT 2 mg/kg | ICP-MS, USP <233> |
| Mercury | NMT 0.1 mg/kg | ICP-MS, USP <233> |
| Residual ethanol | NMT 0.5% w/w | Headspace GC, VICH GL18 |
| Total aerobic microbial count | NMT 1000 CFU/g | ISO 4833-1 |
| Yeast and mould | NMT 100 CFU/g | ISO 21527-1 |
| Escherichia coli | Absent in 1 g or 25 g | ISO 16649-2 |
| Salmonella | Absent in 25 g | ISO 6579-1 |
| Bacterial endotoxins, injectable grade | NMT 0.5 EU/mg | Limulus amoebocyte lysate test |
The limits in the table are representative supplier release criteria for a veterinary-grade extract; they are not necessarily pharmacopoeial requirements for all jurisdictions.
In feed premix and oral liquid manufacturing, the same API lot is incorporated at use rates determined by the target animal species, indication, and registered formulation. For premix operations, the powder is typically diluted with lactose monohydrate, corncob meal, or wheat middlings at ratios from 1:5 to 1:20 before addition to a conical screw mixer or ribbon blender. The medicated premix is then mixed for 10 to 20 minutes to achieve a coefficient of variation below 5.0% for marker content. Dry granular formulations for oral administration through feed or drinking water require a water-dispersible carrier. The API powder itself is only partially soluble in cold water; baicalin dissolves slowly and may settle unless the formulation includes a wetting agent. For oral solutions, a pH between 5.0 and 7.0 is usually maintained because acidic conditions below pH 2.0 can hydrolyse flavonoid glycosides to aglycones, and alkaline conditions above pH 8.0 may promote oxidation of phenolic markers. Polysorbate 80 at 0.1% to 0.5% w/w is sometimes used as a dispersing aid in liquid formulations, but compatibility with the selected preservative system must be verified because non-ionic surfactants can reduce the antimicrobial activity of parabens.
The injectable powder form of this product is not identical to the oral grade. An injectable-grade lot must meet bacterial endotoxin limits, particulate matter limits, and a tighter bioburden specification before terminal sterilisation or aseptic processing. A typical endotoxin limit for a parenteral Shuanghuanglian powder is not more than 0.5 EU/mg of dry extract, based on a parenteral dose not exceeding 25 mg/kg body weight in pigs and cattle. Published data for this specific multi-marker botanical formulation are limited, and the endotoxin limit must be calculated from the registered maximum dose and the animal body weight according to the relevant pharmacopoeial guidance. The dry powder for injection is dissolved in water for injection, filtered through a 0.22 μm membrane, and filled under aseptic conditions, or freeze-dried after sterile filtration. The solution may contain particulates from weakly soluble polyphenols; therefore a clarifying filter followed by a sterilising-grade filter is used. The pH of the reconstituted solution is typically adjusted to 5.0 to 7.0 with a pharmaceutically acceptable buffer. High chloride or sulphate concentrations can salt out phenolic acids; therefore sodium chloride-based isotonicity agents should be evaluated for precipitate formation. Injectable formulations containing Shuanghuanglian should not be mixed in the same intravenous line with strongly acidic products or with oxidising agents because baicalin and chlorogenic acid are susceptible to oxidation and pH-dependent hydrolysis.
| Dosage form | Critical API property | Typical process boundary |
|---|---|---|
| Tablets | Moisture, particle size | NMT 5.0% moisture; 90% ≤ 177 μm; compression 12–22 kN; relative humidity ≤ 40% |
| Hard capsules | Flowability | Angle of repose ≤ 40°; glidant 1.0–2.0% SiO2; fill weight 200–500 mg |
| Oral powders and granules | Dispersibility | Carrier 1:5–1:20; mixing 10–20 min |
| Premix | Uniformity | Marker content CV ≤ 5.0%; lactose or corncob carrier |
| Oral solution | Chemical stability | pH 5.0–7.0; polysorbate 80 0.1–0.5%; avoid pH <2.0 |
| Injectable powder | Endotoxin, particulate load | Endotoxin ≤ 0.5 EU/mg; sterilising filtration 0.22 μm; pH 5.0–7.0 |
The key difference between Shuanghuanglian Powder Veterinary Grade API and a single-entity synthetic veterinary drug such as amoxicillin trihydrate or florfenicol is the absence of a single defined molecular entity responsible for a minimum inhibitory concentration. The extract contains multiple flavonoids, phenolic acids, and lignan glycosides whose relative proportions vary across harvests and extraction campaigns; therefore therapeutic equivalence is controlled by marker content and chromatographic fingerprint similarity instead of a 95% to 105% assay range on one active ingredient. This is a material difference for veterinary drug manufacturers: batch-to-batch consistency of botanical extracts requires dissolution testing and fingerprint profiling, not merely a chemical assay for one compound. The extract is not considered interchangeable with a pharmacopoeial antibiotic, and it is not appropriate for severe acute bacterial sepsis unless the registered indication specifically supports such use. Compared with a crude pulverised herb blend, the spray-dried API has a defined microbial burden, lower heavy-metal variability, and a controlled particle size. The crude powder may contain total aerobic counts exceeding 10 000 CFU/g and may not meet the same ISO 4833-1 limit of 1000 CFU/g; it also lacks a loss-on-drying and residual-solvent specification. Compared with isolated baicalin or chlorogenic acid fractions, the Shuanghuanglian extract retains the multi-constituent profile but is more difficult to standardise to a narrow assay range. The API also differs from aqueous decoction powders used in some traditional formulations by minimising insoluble plant fibre and by specifying a water-soluble carrier for dispersion.
Formulators should also observe that the extract can interact with divalent metal ions, particularly iron and copper, forming dark complexes. Stainless steel contact surfaces are preferred for mixing and milling. The dry powder is combustible under dust-cloud conditions, and open-flame milling or blending should be avoided. For long-term storage, sealed aluminium-foil bags with desiccant are used at or below 25°C and 60% relative humidity; stability studies under these conditions are ordinarily designed for 24 to 36 months, although published data for this specific veterinary-grade configuration are limited.